H ow perinatal events affect short-and long-term neonatal outcomes is a topic of longstanding interest. It has been reported that maternal opioid administration during labor and anesthetic management during delivery may transiently affect neonatal behavior; however, most of these reports were not well controlled for confounding variables. [1] [2] [3] [4] The potential long-term effects of labor anesthesia and analgesia on human development are unknown.
Learning disabilities (LDs) are problems with 1 or more of the basic psychological processes involved in understanding or in using spoken or written language, which may manifest itself in an imperfect ability to listen, think, speak, read, write, spell, or do mathematical calculations. We recently reported that the incidence of LDs diagnosed before age 19 years was lower in a population-based birth cohort of children delivered of mothers who received neuraxial anesthesia for cesarean delivery compared with both children delivered vaginally and children delivered via cesarean delivery with general anesthesia. 5 The potential mechanism for this surprising finding is not known, but we speculated that it could relate to differences in maternal and fetal stress among the delivery techniques, based on the suggestion that the stress of labor may cause long-lasting behavioral effects in children. 6 Studies in animal models also found an association between peripartum stress and long-term behavioral outcomes. [7] [8] [9] [10] Elective cesarean delivery more effectively attenuates fetal and maternal hormonal stress responses compared with vaginal delivery. 11 In our prior study, the use of neuraxial anesthesia for cesarean delivery (most of which were scheduled in nonlaboring women) could have suppressed the stress responses and improved long-term neurobehavioral outcomes. 5 However, this was an observational study involving many factors that were not controlled and thus is best interpreted as hypothesis-generating. Although prolonged antepartum maternal stress has been linked to adverse neurobehavioral outcomes in children, 12, 13 it is less certain whether a single stress episode, such as one that occurs during labor and delivery, could contribute to long-lasting neurobehavioral outcomes. 6, 14, 15 In particular, whether peripartum stress has a role in the development of LDs is not known.
Epidural analgesia administered for labor decreases markers of both maternal and fetal stress such as cortisol. 11, 14, 16 If fetal stress had a role in the observed differences in the incidence of LDs among delivery methods in our previous study, we speculated that neuraxial labor analgesia might also affect long-term outcomes after vaginal delivery. The purpose of this study was to test the hypothesis that the incidence of LDs is lower in children whose mothers received neuraxial labor analgesia for vaginal delivery compared with those whose mothers did not.
METHODS
The Mayo Clinic and Olmsted Medical Center IRBs (both located in Rochester, MN) approved this study. In compliance with Minnesota law (Minnesota Statute 144.335 [Subd. 3a. (d)]), only data from patients who provided research authorization for the use of their medical records were included in the study. A birth cohort of children born in Rochester, MN identified in prior work by the authors [17] [18] [19] [20] [21] [22] [23] formed the basis of the present study, and we have previously summarized the methods used to collect these data. 5, 24 Thus, the cohort used for this study represents a subset of the cohort analyzed previously. 5, 22, 24, 25 All children born between January 1, 1976 and December 31, 1982 to mothers residing at the time of delivery in the area of 5 Olmsted County, Minnesota townships comprising the Rochester public school system were identified through computerized birth certificate information (n ϭ 8548). Vital status (still living in Rochester, moved, or deceased) was determined for each member of the birth cohort during the 1995 to 1996 school year through the Rochester Epidemiology Project. 26 Children who left Olmstead County before age 5 years (i.e., moved or died, n ϭ 2830) were not included in the final study cohort. 17 Through the Rochester Epidemiology Project, all diagnoses and surgical procedures recorded at all Rochester medical facilities are indexed for automated retrieval. Through a contractual research agreement, all public (19 primary, 3 junior high, and 3 high schools) and nonpublic (12 primary, 10 junior high, and 4 high schools) schools gave permission to access their richly documented cumulative educational records for every child from this birth cohort. Under a second research agreement, permission was obtained to access the resources of the privately owned Reading Center/Dyslexia Institute of Minnesota, the only private tutoring agency in the community during the years relevant to this study. Thus, the overall strategy for identifying all children in this cohort with LDs used multiple sources of information that provided a richly documented history of any learning/behavior concerns, information of educational intervention, and individually administered test results.
Identification of LDs
The details of LD ascertainment have been described in prior reports examining the epidemiology of LDs. 17,18,20 -23 To summarize, all school, medical, and Reading Center/ Dyslexia Institute records were reviewed by trained personnel who used detailed data abstraction protocols, seeking evidence for reported learning difficulties. Based on the initial review, potential LD was identified in 1510 children (26% of the birth cohort, n ϭ 5718). The results of individually administered intelligence quotient (IQ) (primarily ageappropriate Wechsler scales) and achievement (primarily Woodcock-Johnson tests) tests, and medical, educational, and socioeconomic information were abstracted. Research criteria using an average of 2 individually administered IQ and 3 individually administered achievement tests were then applied to these children to diagnose reading, written language, and math LDs. Children were classified as having LDs if they met criteria according to at least 1 of 3 standard formulas. In each of the following formulas, X is equal to the study subject's IQ score, and Y represents the predicted standard score from the achievement test. (1) The regression formula-Minnesota (Y Ͻ 17.40 ϩ 0.62X) is issued by the Minnesota Department of Education. 27 Children classified as having LDs by this formula had standard scores in academic achievement that were Ͼ1.75 SD below their predicted standard score from an individually administered measure of cognitive ability (IQ). The value 0.62 represents the correlation between IQ and achievement used in the formula from the state of Minnesota. (2) The discrepancy nonregression method was used in Minnesota Independent School District No. 535 before 1989 and included the school years of the children in the birth cohort. By using this approach, differences between standard scores on measures of intelligence, aptitude, and measures of test achievement that were believed to be important varied by grade as follows: (a) kindergarten to 3rd grade, Ն15 standard score points difference, with achievement lower; (b) 4th to 6th grade, Ն19 points difference, achievement lower; and (c) 7th to 12th grade, Ն23 points difference. (3) Finally, the low-achievement method (X Ն 80 [aptitude] and Y Յ 90 Յ achievement]) represents a recent concept in identifying LDs independent of measured cognitive ability, assuming that cognitive ability is at least in the low average range. 28 Children meeting the criteria before age 19 years for at least 1 of the 3 LDs (reading, written language, and math disorders) using IQ and achievement scores obtained within the same calendar year were identified as LD cases regardless of presence or absence of any comorbid conditions. Children with moderate/severe mental retardation (IQ Ͻ50) were excluded from the cohort.
Other Variables
We identified all children within the cohort who were delivered vaginally. The following information was abstracted from the anesthesia records: use of neuraxial analgesia during labor and delivery (epidural or spinal), other regional blocks used during labor (e.g., pudendal and paracervical nerve blocks), and the use of opioids, benzodiazepines, and any adjuvant inhalation anesthetics. Age and education (Ͻ12 years [some high school education], 12 years [high school graduate], and Ͼ12 years [any postsecondary education]) for both mother and father were recorded from school records and birth certificates. Pregnancy complications were abstracted from the birth certificates, including preeclampsia and eclampsia, hemorrhage during pregnancy, premature rupture of membranes, and abnormalities of the placentation. Information obtained for each child included sex, gestational age at birth, birth weight, induced labor, instrumental vaginal delivery (forceps or vacuum extraction), complications of labor and delivery (hemorrhage during delivery, fetopelvic disproportion, dystocia [abnormal fetal position that slowed labor progression], prolonged labor, umbilical cord compression, birth trauma, and intrauterine hypoxia), and Apgar scores at 5 minutes (these data were gathered from the labor and delivery "check list" entered by the delivering obstetrician). Finally, we reviewed requirements for neonatal resuscitation immediately after delivery and admission to the neonatal intensive care unit.
Statistical Analysis
The primary outcome for the current analysis was LDs based on individually administered IQ and academic achievement test scores using any of the 3 standard formulas for determining the presence of reading, written language, or math LDs. The primary risk factor of interest for this investigation was the association between LDs and exposure to neuraxial labor analgesia. Analyses were performed to compare demographic, pregnancy and delivery complications, and parental characteristics across 2 delivery analgesic regimens (no neuraxial block versus neuraxial analgesia) using the Student 2-sample t test for continuous variables and the 2 test (or Fisher exact test) for categorical variables. Individuals were followed from birth until the date they first met the LDs criteria using any of the 3 standard formulas. Cumulative incidence rates of LDs were calculated according to the method of Kaplan and Meier with data censored at the initial occurrence of emigration, death, last follow-up date, or the age of 19 years. Proportional hazards regression was used to assess whether use of neuraxial analgesia was significantly associated with LDs. Both unadjusted and adjusted analyses were performed. For the first adjusted analysis, the following covariates were selected a priori based on previous work 17, 18, 22, 29 and included gestational age (Յ31 weeks, 32-36 weeks, Ն37 weeks), sex, birth weight (Ͻ2500 g, Ն2500 g), maternal education (some high school, high school graduate, any college), 5-minute Apgar score, and number of anesthesia exposures before the age of 4 years (0, 1, 2 or more). 24 For the second adjusted analysis, in addition to factors included in the first analysis, we also included as covariates other factors that we deemed potentially relevant or were significantly (P Ͻ 0.05) different between the 2 groups in univariate analysis, such as use of forceps or vacuum extraction (any versus none), fetal presentation (cephalic versus all other presentations), dystocia, prolonged labor, birth trauma, inhaled analgesia during labor and delivery, supplemental regional blocks (pudendal and paracervical), systemic opioid analgesia, labor induction, neonatal resuscitation or admission to the neonatal intensive care unit after delivery, and maternal age. Proportional hazards assumptions were checked with the use of scaled Schoenfeld residuals. 30 Results were summarized using hazard ratio estimates and corresponding 95% confidence intervals (CIs). In all cases, 2-tailed P values Ͻ0.05 were considered to be statistically significant. Analyses were performed using SAS statistical software (Version 9.1; SAS Institute, Inc., Cary, NC).
RESULTS
Between 1976 and 1982, 8548 children were born and 5718 of these children still resided in the community at 5 years of age. Of these, 398 were excluded because of moderate/severe mental retardation (19 children) or because the parents denied research authorization (379 children). Of the 5320 children who were included in our previous report, 5 4823 were delivered vaginally. Of these, 139 were excluded because the pertinent information from the mother's medical records regarding birth characteristics and/or neuraxial analgesia information were missing. Therefore, the present cohort consists of 4684 vaginal births (3189 births without neuraxial analgesia and 1495 with neuraxial analgesia, including 1274 epidural blocks and 221 spinal blocks).
Mothers who received neuraxial analgesia were younger than those who did not; otherwise, there were no differences in parent and child demographic characteristics ( Table 1 ). The absolute rate of pregnancy complications was low, but mothers who received neuraxial analgesia were more likely to have had preeclampsia or eclampsia. The birth weights and gestational ages of the neonates were comparable between groups.
Use of neuraxial analgesia was associated with a higher frequency of cephalic presentation, induction of labor, and labor/delivery complications; the most common complication was prolonged labor (Table 2) . Also, mothers who received neuraxial analgesia had an approximately 4-fold higher rate of forceps-or vacuum-assisted deliveries. The median 5-minute Apgar score was lower in the neuraxial analgesia group, but there was no difference in the rate of neonatal resuscitation or neonatal intensive care unit admission. Mothers who did not receive neuraxial analgesia were more likely to receive supplemental systemic opioid analgesia, paracervical and pudendal regional blocks, and inhaled anesthetics (mostly nitrous oxide or methoxyflurane) ( Table 3 ). The percentage of children who underwent surgical procedures under the age of 4 years did not differ between those born to mothers who received neuraxial analgesia (89.3%, 8.5%, and 2.2% undergoing 0, 1, and 2 or more operations, respectively) and those born to mothers who did not receive neuraxial analgesia (89.4%, 8.0%, and 2.6%; P ϭ 0.62).
Within the cohort, 818 children were diagnosed with LDs before the age of 19 years. The cumulative incidence of LDs at age 19 years among those who were delivered vaginally without neuraxial analgesia was 19.6% (95% CI, 18.1%-21.1%) compared with 22.7% (95% CI, 20.3%-24.1%) for those whose mothers received neuraxial analgesia. In the proportional hazard regression analysis, the unadjusted risk for LDs was higher in children born to mothers who received neuraxial analgesia compared with those who did not (Table 4 ). However, after adjusting for covariates that were previously shown to be associated with LDs, this risk was not significantly different between groups, nor was it different after further adjustment for additional peripartum maternal and child variables. To assess which of the additional covariates most attenuated the increased risk of LDs associated with the use of neuraxial analgesia in the unadjusted analysis, a series of post hoc analyses were performed. Each covariate was assessed individually by including it in a model along with neuraxial analgesia and the other covariates previously shown to be associated with LDs. The largest reduction in the hazard ratio associated with neuraxial analgesia was found when "instrumented Values are mean (SD) or n (%). Data were complete for Ͼ99% of the study sample for all characteristics with the exception of gestational age, which was missing for 295 (6.3%); mother's education was missing in 405 (8.7%), and father's education in 645 (13.8%). delivery" was included as an additional covariate. In the post hoc model that included this additional risk factor, the hazard ratio for neuraxial analgesia was 1.09 (95% CI, 0.91-1.31; P ϭ 0.35).
DISCUSSION
The pathogenesis of LDs is poorly understood but likely involves a combination of genetic and environmental factors. 31, 32 Human neurodevelopment is especially vulnerable to pharmacological and environmental insults 33, 34 and the most sensitive period is between the third trimester of pregnancy to several years (3-4) after birth. 33 In animal models, exposure to sedatives and anesthetics during the critical periods of rapid neural development may cause accelerated neuroapoptosis [35] [36] [37] [38] [39] associated with impaired learning and memory. 36, 40 In prior work, we reported that exposure to anesthesia before age 4 years was a risk factor for the development of LDs in children receiving multiple, but not single, anesthetics. 24 Although the lack of association between a single anesthetic exposure and LDs is reassuring, 24 it is still possible that a brief exposure of the neonatal brain to anesthetic during delivery might be neurotoxic. Therefore, we subsequently examined the association between neonatal exposure to anesthesia during cesarean delivery and the development of LDs. 5 Children exposed to general anesthesia during cesarean delivery were not more likely to develop LDs compared with children delivered vaginally. However, an unexpected finding was that the adjusted risk of LDs was lower in children delivered via cesarean delivery under neuraxial anesthesia. The potential effects of anesthetic technique used during delivery on long-term neurodevelopmental outcomes in humans are not known. A single primate study examined the effects of bupivacaine administered via epidural to nonlaboring rhesus monkeys at term, and found no effects on learning, memory, and attention domains at 1 year of age. 41 We speculated that our previous finding might be explained by a reduction in the labor and delivery stress with neuraxial anesthesia. 5 Prenatal stress in animals may induce synaptic loss causing long-term learning abnormalities in offspring. 7, 8, 10 Human fetal stress during pregnancy and during the peripartum period can produce lasting organizational changes that can be associated with abnormal behaviors and altered cognitive and language development. 6, 13, 15, [42] [43] [44] [45] For example, children with a higher intensity of perinatal stressors may have an increased rate of attention deficit hyperactivity disorder, 46 as well as altered personality and depressive disorders. 13, 47 The potential role of perinatal stress on development, specifically the incidence of LDs, is not known. Perinatal stresses such as Data are n (%). a In the "no neuraxial block" group: enflurane (n ϭ 1), nitrous oxide and enflurane (n ϭ 2), methoxyflurane and enflurane (n ϭ 1), halothane and nitrous oxide (n ϭ 1), the use of inhaled anesthetic indicated in medical records, but anesthesia record is missing (n ϭ 2). In the "neuraxial block" group: halothane and nitrous oxide (n ϭ 1). , birth weight (Ͻ2500 g, Ն2500 g), maternal education (some high school, high school graduate, any college), 5-min Apgar score, and number of anesthesia exposures before the age of 4 y (0, 1, 2 or more). c Adjusted for covariates included in initial adjusted model plus use of forceps or vacuum extraction, fetal presentation, dystocia, prolonged labor, birth trauma, use of any inhaled anesthetics during delivery, use of supplemental regional blocks, use of opioids, labor induction, delivery resuscitation or neonatal intensive care unit admission after delivery, and maternal age.
vaginal delivery and neonatal circumcision can alter endocrine markers of stress responses to painful stimuli that are detectable months after delivery, 6, 14, 15 and for the latter, local anesthetic for circumcision may modulate this response. 15 The mechanisms responsible may involve exposure of neural tissues to corticosteroids released during stress. 48 -50 For example, a prospective randomized study on premature neonates found a positive association between immediate postdelivery week-long administration of dexamethasone and worse neurologic and motor function, cognition, and school performance at age 5. 51 Labor and delivery are associated with significant stress. As assessed by cortisol levels, the intensity of maternal and fetal stress decreases from vaginal delivery with instrumentation, to unassisted vaginal delivery, and is least with cesarean delivery. 11, 14, 52 Combined spinal-epidural used during labor is associated with reduced umbilical cord cortisol concentrations independent of delivery mode. 14 Epidural anesthesia for cesarean delivery significantly reduces fetal cord blood cortisol levels compared with levels in infants born vaginally. 11 We speculated that if such reductions in stress mediated the favorable effects of cesarean delivery with neuraxial anesthesia on the incidence of LDs observed in our prior study, 5 then labor neuraxial analgesia might have similar beneficial effects in children delivered vaginally. However, we found that the use of neuraxial analgesia does not have a protective effect on the development of LDs. Rather, before adjusting for covariates, labor neuraxial analgesia was found to be associated with a small, but statistically significant, increase in the risk of LDs. This risk was no longer significant after inclusion of covariates previously shown to be associated with risk for LDs, 5, 24 and was further reduced in an expanded multivariable model that included numerous peripartum covariates. These findings suggest that the use of neuraxial analgesia per se likely does not have a significant impact on the development of LDs, but rather, may be associated with other factors such as the need for instrumented delivery, which could affect the incidence of LDs. Indeed, postpartum arterial cord cortisol levels are more elevated in neonates whose deliveries are assisted. 14 Several factors could explain the lack of effect of neuraxial analgesia on incidence of LDs. Although neuraxial analgesia can attenuate some measures of maternal stress responses, 11, 16 its effects on neonatal stress responses are less clear. The effects of epidural labor analgesia on neonatal cortisol levels is not well studied, with 1 small study finding no effect 11 and another larger study finding a decrease in cortisol levels. 14 We have no data regarding the quality of analgesia achieved by the neuraxial analgesia, and other analgesics were used in both groups. In addition, neuraxial analgesia does not prevent psychological stress associated with delivery, which may have a significant role in increasing stress hormones regardless of the level of pain control. 53 Thus, it is possible that there was little or no difference in the stress experienced by the neonates in the 2 groups. Also, it is possible that the high frequency of assisted deliveries in the neuraxial group may have increased fetal stress, 11, 14, 52 counterbalancing any beneficial stress-reducing effects of neuraxial analgesia that the mother might experience.
Finally, it is possible that short but extreme neonatal stress during delivery has no role in the development of LDs and cannot explain our prior results observed with neuraxial anesthesia during cesarean delivery. 5 We have extensively discussed the limitations with both the birth cohort and this type of analysis. 5, 24 Most importantly, in our multivariable analysis, we adjusted for risk factors known to be associated with the risk of LDs and covariates for several peripartum characteristics found to differ significantly between groups, and we found no significant association between the use of labor neuraxial analgesia and the incidence of childhood LDs. However, we cannot exclude the possibility that other confounding variables that were not available in this study could have affected our findings. Another limitation is that techniques used to provide neuraxial analgesia for labor and delivery during the study period differ from contemporary practice. These women received 0.25% bupivacaine as intermittent bolus only, compared with current practices that often use continuous infusions of low-dose local anesthetic solutions, frequently with opioids and combined spinal-epidural techniques. Finally, with 818 events observed in a total sample size of 4684 of whom 1495 (32%) received neuraxial analgesia, and 3189 (68%) who did not receive neuraxial analgesia, our study provided statistical power (2-tailed, ␣ ϭ 0.05) of Ͼ80% to detect a hazard ratio of 1.25. However, based on the upper limit of the 95% CI for the hazard ratio, we cannot exclude the possibility of smaller but significant effect sizes.
In conclusion, the maternal use of neuraxial labor analgesia during labor and vaginal delivery in this population was not an independent risk factor for the subsequent development of childhood LDs. Future studies are needed to evaluate potential mechanisms/explanation of our previous findings that the incidence of LDs is lower in children born to mothers via cesarean delivery under neuraxial anesthesia compared with vaginal delivery.
